Companies / Dominican Republic
Sanofi-Aventis Gears Up For Plavix Patent Battle
March 2008 | Industry NewsFrance's Sanofi-Aventis is gearing up for a battle over the validity of its patent for anti-clotting agent Plavix (clopidogrel) in the Dominican Republic, according to the Dominican Association of Pharmaceutical Industries (Infadomi). Local drugmaker Dominican Laboratory Linea SA has launched generic clopidogrel, which, according to Sanofi-Aventis, infringes its local Plavix
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
